| scholarly article | Q13442814 |
| P50 | author | John T. Brooks | Q93069508 |
| P2093 | author name string | Christopher M Jones | |
| Brian Lewis | |||
| Charles E Rose | |||
| Kashif Iqbal | |||
| John W Ward | |||
| Azfar-E-Alam Siddiqi | |||
| Jon E Zibbell | |||
| Michele K Bohm | |||
| Jonathan H Mermin | |||
| Eugene McCray | |||
| Michelle M Van Handel | |||
| Elaine J Hallisey | |||
| Barry E Flanagan | |||
| Andrew L Dent | |||
| Jessica L Kolling | |||
| P2860 | cites work | Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States | Q28396625 |
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012. | Q30209037 | ||
| Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015. | Q34474460 | ||
| Supply of buprenorphine waivered physicians: the influence of state policies | Q35571613 | ||
| Patterns of prescription drug misuse among young injection drug users. | Q36491880 | ||
| Underascertainment of acute hepatitis C virus infections in the U.S. surveillance system: a case series and chart review | Q36514676 | ||
| The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction | Q38315269 | ||
| Drug poisoning deaths in the United States, 1980-2008. | Q39247517 | ||
| Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012. | Q40278327 | ||
| Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013. | Q40754700 | ||
| Drug-poisoning deaths involving heroin: United States, 2000-2013. | Q40988166 | ||
| Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010. | Q43469663 | ||
| Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors | Q43824699 | ||
| Notes from the field : hepatitis C virus infections among young adults--rural Wisconsin, 2010. | Q45357595 | ||
| Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009. | Q45366817 | ||
| Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users--new York, November 2004-April 2007. | Q45395054 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United States of America | Q30 |
| HIV | Q15787 | ||
| vulnerability assessment | Q1400839 | ||
| P304 | page(s) | 323-331 | |
| P577 | publication date | 2016-11-01 | |
| P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
| P1476 | title | County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States | |
| P478 | volume | 73 |
| Q90446884 | "Money Helps": People who inject drugs and their perceptions of financial compensation and its ethical implications |
| Q31162537 | A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care |
| Q89877496 | A vulnerability assessment for the HCV infections associated with injection drug use |
| Q97589309 | A vulnerability index for the management of and response to the COVID-19 epidemic in India: an ecological study |
| Q93018582 | Acceptability of safe drug consumption spaces among people who inject drugs in rural West Virginia |
| Q55249891 | Access to Syringe Services Programs - Kentucky, North Carolina, and West Virginia, 2013-2017. |
| Q61442923 | Assessing Differences in CDC-Funded HIV Testing by Urbanicity, United States, 2016 |
| Q94460547 | Barriers and facilitators to retaining a cohort of street-based cisgender female sex workers recruited in Baltimore, Maryland, USA: results from the SAPPHIRE study |
| Q90730745 | Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky |
| Q59360577 | Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C |
| Q89041505 | Charting the Course to End HIV Transmission in the United States |
| Q59794773 | Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach |
| Q90009502 | Community Perceptions of Comprehensive Harm Reduction Programs and Stigma Towards People Who Inject Drugs in Rural Virginia |
| Q92139384 | Confronting the opioid epidemic: public opinion toward the expansion of treatment services in Virginia |
| Q40097145 | Considerations for the Development of a Substance-Related Care and Prevention Continuum Model |
| Q40144468 | Correlates of Injection Drug Use Among Rural Appalachian Women |
| Q47613634 | Detailed Transmission Network Analysis of a Large Opiate-Driven Outbreak of HIV Infection in the United States |
| Q91471427 | Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011-15: a modelling study |
| Q59359311 | Emergency departments at the crossroads of intersecting epidemics (HIV, HCV, injection drug use and opioid overdose)-Estimating HCV incidence in an urban emergency department population |
| Q64073030 | Estimating the Number of People Who Inject Drugs in A Rural County in Appalachia |
| Q33696050 | Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010 |
| Q89801246 | Expansion of Syringe Service Programs in the United States, 2015-2018 |
| Q92410418 | Facilitators and Barriers: Clients' Perspective on the Virginia AIDS Drug Assistance Program's Affordable Care Act Implementation |
| Q89536780 | Feasibility and Acceptability of an mHealth-Based Approach as an HIV Prevention Strategy Among People Who Use Drugs on Pre-Exposure Prophylaxis |
| Q38840669 | Geographic Disparities in Access to Syringe Services Programs Among Young Persons With Hepatitis C Virus Infection in the United States |
| Q38400394 | HIV Care Initiation Delay among Rural Residents in the Southeastern United States, 1996 to 2012. |
| Q39007916 | HIV Infection in Hard-to-Reach Populations. |
| Q89359653 | HIV Prevention in Rural Appalachian Jails: Implications for Re-entry Risk Reduction Among Women Who Use Drugs |
| Q52595592 | HIV and viral hepatitis coinfection analysis using surveillance data from 15 US states and two cities. |
| Q56884713 | HIV-1 Transmission Clustering and Phylodynamics Highlight the Important Role of Young Men Who Have Sex with Men |
| Q89184080 | HIV/HCV Co-infection: Burden of Disease and Care Strategies in Appalachia |
| Q59357438 | Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care Providers |
| Q59359721 | Hepatitis C antibody reactivity among high-risk rural women: opportunities for services and treatment in the criminal justice system |
| Q56977768 | Hepatitis E: we have seen the footprint in the sand, let us hunt the beast |
| Q55109199 | Human immunodeficiency virus and liver disease: A comprehensive update. |
| Q90166144 | I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018 |
| Q64076054 | Identifying Areas with Disproportionate Local Health Department Services Relative to Opioid Overdose, HIV and Hepatitis C Diagnosis Rates: A Study of Rural Illinois |
| Q56888156 | Identifying Clusters of Recent and Rapid HIV Transmission Through Analysis of Molecular Surveillance Data |
| Q47734540 | Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas - United States. |
| Q47584436 | Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas-United States. |
| Q89286341 | Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment |
| Q88773628 | Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review |
| Q55425578 | Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV? |
| Q33853664 | Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection. |
| Q64267726 | Medications for Treatment of Opioid Use Disorder among Persons Living with HIV |
| Q44351165 | Medications for opioid use disorder: bridging the gap in care |
| Q49862666 | Network-Based Research on Rural Opioid Use: an Overview of Methods and Lessons Learned |
| Q92709847 | New possibilities on transplanting kidneys from hepatitis C virus positive donors: a Systematic Review |
| Q91471430 | No more Scott Counties |
| Q54264145 | Notes from the Field: HIV Infection Investigation in a Rural Area - West Virginia, 2017. |
| Q64073808 | Novel Method for Rapid Detection of Spatiotemporal HIV Clusters Potentially Warranting Intervention |
| Q99549948 | Novel Recruitment Methods for Research Among Young Adults in Rural Areas Who Use Opioids: Cookouts, Coupons, and Community-Based Staff |
| Q99548922 | Opioid Use Disorders in People Living with HIV/AIDS: A Review of Implications for Patient Outcomes, Drug Interactions, and Neurocognitive Disorders |
| Q90220869 | Opioid use trajectory groups and changes in a physical health biomarker among HIV-positive and uninfected patients receiving opioid agonist treatment |
| Q52315227 | Opioids, Hepatitis C Virus Infection, and the Missing Vaccine. |
| Q64100871 | Outbreak of Human Immunodeficiency Virus Infection Among Heterosexual Persons Who Are Living Homeless and Inject Drugs - Seattle, Washington, 2018 |
| Q52622035 | Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US. |
| Q33629173 | Prescribing of Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis by HIV Medical Providers in the United States, 2013-2014 |
| Q57790191 | Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: a retrospective cohort study |
| Q38666907 | Scaling up HCV prevention and treatment interventions in rural USA - model projections for tackling an increasing epidemic |
| Q40083334 | Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley |
| Q45070698 | Substance Use in Rural Central Appalachia: Current Status and Treatment Considerations |
| Q47330462 | Tennessee's In-State Vulnerability Assessment for a 'Rapid Dissemination of HIV or HCV Infection' Event Utilizing Data about the Opioid Epidemic |
| Q103004978 | The CTSA program's role in improving rural public health: Community-engaged disease prevention and health care innovation |
| Q30268556 | The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions |
| Q90592520 | The Health Resources and Services Administration's Ryan White HIV/AIDS Program in rural areas of the United States: Geographic distribution, provider characteristics, and clinical outcomes |
| Q41918149 | The Rise of the Opioid Epidemic and Hepatitis C Positive Organs: A New Era in Liver Transplantation |
| Q49824510 | The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions |
| Q52601050 | The opioid epidemic and injection drug use: MIPIE and health harms related to the injection of prescription opioids. |
| Q92489291 | The opioid epidemic in rural northern New England: An approach to epidemiologic, policy, and legal surveillance |
| Q64271311 | Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs |
| Q38753617 | Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era. |
| Q47300268 | Viral Hepatitis Strategic Information to Achieve Elimination by 2030: Key Elements for HIV Program Managers. |
| Q92871691 | Web-Based Eligibility Quizzes to Verify Opioid Use and County Residence Among Rural Young Adults: Eligibility Screening Results from a Feasibility Study |
| Q100416678 | Working Toward Elimination of Hepatitis C: The Kentucky Hepatitis Academic Mentorship Program |
Search more.